Literature DB >> 15846583

Iron overload in thalassemia and sickle cell disease.

A Taher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15846583     DOI： 10.1053/j.seminhematol.2005.01.005

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  3 in total

Review 1.  Deferasirox: oral, once daily iron chelator--an expert opinion.

Authors:  M B Agarwal
Journal:  Indian J Pediatr       Date:  2010-02-23       Impact factor: 1.967

2.  Current therapy of sickle cell disease.

Authors:  Zakari Y Aliyu; Ashaunta R Tumblin; Gregory J Kato
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

Review 3.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.